SLE Patients with Antiphospholipid Antibodies at Risk for Pulmonary Hypertension, Study Finds

The presence of antiphospholipid antibodies (aPL) in circulation may aid identify patients at risk for pulmonary hypertension (PH) and associated pulmonary arterial hypertension (PAH) among people who already have systemic lupus erythematosus (SLE). So says a study, “Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension:…